Premature Infants Clinical Trial
The investigators hypothesize that Recorded Home Oximetry (RHO) utilization will not increase rates of respiratory-related re-hospitalizations and ED visits, and will not impair growth compared to standard oxygen management protocols. Evidence-based specific consensus guidelines for home regulated oxygen management do not currently exist. Current strategies for infants requiring outpatient supplemental home oxygen include brief checks of oxygen status during monthly clinic visits. Although the infants stay on monitors, no data in between visits is obtained to ensure that infants can maintain oxygen levels after weans are made. Before finally allowing oxygen to be removed, many centers also require an overnight sleep study in the hospital, to make sure that the infant's oxygen levels stay safe when the infant is in deep sleep. Because these methods rely solely on assumptions rather than individually recorded data, an infant's time on supplemental oxygen may be prolonged or insufficient. This study will evaluate both the currently used accepted therapy and a method of weaning that involves recording and sending oxygen data for analysis in between clinic visits. Premature infants who require home oxygen therapy at time of discharge who meet eligibility criteria will be randomized into two arms: Arm A ("Standard therapy"): Infants' oxygen will be increased, decreased, or maintained based on brief structured assessments during monthly clinic visits. Arm B (Recorded Home Oximetry (RHO)): Infants will have the same monthly clinic assessments as in Arm A, but also will utilize Recorded Home Oximetry (RHO) to potentially increase, decrease or maintain oxygen between monthly visits. Parents of all infants will be interviewed using structured quality-of-life questionnaires at the beginning and ending of the oxygen management process. Health care utilization (emergency department visits and rehospitalizations) and growth will be assessed 6 months after discontinuation of oxygen. The investigators overall objective is to determine whether Recorded Home Oximetry (RHO) can improve caregiver quality of life, and can shorten Home Oxygen Therapy (HOT) duration and eliminate need for polysomnogram, without compromising safety. The investigators will determine respiratory-related re-hospitalizations, emergency department (ED) visits, and growth parameters to confirm safety of the proposed weaning strategies.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02785926 -
Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates
|
||
Completed |
NCT01946971 -
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)
|
Phase 1/Phase 2 | |
Completed |
NCT01530360 -
Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants
|
Phase 1 | |
Completed |
NCT00681018 -
Feeding Study in Premature Infants
|
N/A | |
Completed |
NCT00217191 -
Ibuprofen and Renal Function in Premature Infants
|
Phase 4 | |
Completed |
NCT01077271 -
Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA
|
N/A | |
Completed |
NCT00282113 -
Effects of Probiotic and Prebiotic Combinations on Premature Infants
|
N/A | |
Active, not recruiting |
NCT02943746 -
Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants
|
N/A | |
Completed |
NCT00389909 -
Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants
|
Phase 4 | |
Completed |
NCT00747591 -
Urine Concentration of S100B in Extremely Premature Infants
|
N/A | |
Recruiting |
NCT04555590 -
Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants
|
N/A | |
Completed |
NCT06352047 -
The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions
|
N/A | |
Completed |
NCT03217045 -
Nutrition Protocol and Premature Infants' Growth
|
||
Recruiting |
NCT03552952 -
Development of Preterm Infant Gut Microbiome
|
||
Recruiting |
NCT06332521 -
Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment
|
||
Completed |
NCT04659083 -
How NAVA Works in Preterm Infants With Irregular Respiratory Efforts
|
||
Completed |
NCT05807191 -
The Effect of Using Clinical Guidelines on Kangaroo Care on Newborn and Maternal Outcomes
|
N/A | |
Completed |
NCT03914690 -
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
|
Phase 2 | |
Completed |
NCT01140243 -
Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital
|
N/A | |
Completed |
NCT00957840 -
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
|
N/A |